3beta-(n-(n',n'-dimethylaminoethane)carbamoyl)cholesterol and HIV Coinfection

3beta-(n-(n',n'-dimethylaminoethane)carbamoyl)cholesterol has been researched along with HIV Coinfection in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Chêne, G; Gaillard, C; Hocini, H; Journot, V; Launay, O; Mathieu, E; Pérusat, S; Petitprez, K; Pialoux, G; Salmon-Ceron, D; Silberman, B; Slama, L	1

Trials

1 trial(s) available for 3beta-(n-(n',n'-dimethylaminoethane)carbamoyl)cholesterol and HIV Coinfection

Article	Year
Phase I study of a candidate vaccine based on recombinant HIV-1 gp160 (MN/LAI) administered by the mucosal route to HIV-seronegative volunteers: the ANRS VAC14 study. Vaccine, 2008, May-19, Volume: 26, Issue:21 Topics: Adjuvants, Immunologic; Administration, Intranasal; Administration, Intravaginal; Adult; AIDS Vaccines; Cervix Uteri; Cholesterol; Female; HIV Antibodies; HIV Envelope Protein gp160; HIV Infections; Humans; Immunoglobulin A; Middle Aged; Nasal Mucosa; Recombinant Proteins; Saliva	2008

Article

Year

Phase I study of a candidate vaccine based on recombinant HIV-1 gp160 (MN/LAI) administered by the mucosal route to HIV-seronegative volunteers: the ANRS VAC14 study.

Vaccine, 2008, May-19, Volume: 26, Issue:21

Topics: Adjuvants, Immunologic; Administration, Intranasal; Administration, Intravaginal; Adult; AIDS Vaccines; Cervix Uteri; Cholesterol; Female; HIV Antibodies; HIV Envelope Protein gp160; HIV Infections; Humans; Immunoglobulin A; Middle Aged; Nasal Mucosa; Recombinant Proteins; Saliva

2008